1.Choi HK，Merkel PA, Walker AM, et al. Drug-associated anlineu-trophil cytoplasmic antibody-Positive vasculitis：prevalence among pa-tients with high titers of antimyeloperoxidase antibodies [J].Arthritis Rheum,2000,43:405-413
2.Kitahara T, Hiromura K, Maezawa A, et al. Case of prophlthiou racil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody(ANCA):review of literature[J].clin Nephrol, 1997,47:336～340
3.De vriese A S.Robbrechl DL, Van hokler RC,el al.Rifampicin associat-ed acule renal failure：Path physiologic, immunologic, and clinical fea-tures [J].Am J Kidney Dis，1998,21 (1):108
4.NohJY, Asari T,Hacada N,et al,Frequency of appearance of cyelope rox-idase amineahopltil cytoplascic a rnibody (MPO-ANCA)Graves’dis-ease patients treated with propy Ithioaracil and the relationship between MPO-ANCA and clinical canifestations [J]. Clin Endocrinol (oxf),2001,54(5)：651-654
5.Sato H, Hattori M, Fajie da M, etal. High prevaleve of antine utrophil cy-toplascic antibody poeitirity on ohildhood onset Graves' disease treated with propylt-hiouracil [J], J clin Endocnnal Metab, 2000, 85 (11)：4270-4273
6.Sera N, Ashizawa K, Ando T，etal，treat cent withappearance of antineat-rophil cytoplascic antibodies on soce patients with Graves' disease[J] Thyroid，2000,10(7)：595-599
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
